Healthcare provider profile · identity verified

Yuriy Levin, MD

Internal Medicine · SALEM, MA · NPI 1295781003

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	466	156
Amlodipine Besylate	Amlodipine Besylate	347	103
Lisinopril	Lisinopril	298	100
Omeprazole	Omeprazole	298	98
Metoprolol Succinate	Metoprolol Succinate	269	75
Valsartan	Valsartan	207	60
Levothyroxine Sodium	Levothyroxine Sodium	189	45
Gabapentin	Gabapentin	159	41
Eliquis	Apixaban	143	32
Hydrochlorothiazide	Hydrochlorothiazide	138	44
Rosuvastatin Calcium	Rosuvastatin Calcium	117	39
Sertraline Hcl	Sertraline Hcl	113	36
Simvastatin	Simvastatin	107	40
Lorazepam	Lorazepam	106	34
Trazodone Hcl	Trazodone Hcl	106	36
Metformin Hcl Er	Metformin Hcl	102	29
Allopurinol	Allopurinol	95	31
Metformin Hcl	Metformin Hcl	93	30
Losartan Potassium	Losartan Potassium	91	26
Albuterol Sulfate Hfa	Albuterol Sulfate	89	32
Olmesartan Medoxomil	Olmesartan Medoxomil	88	20
Alprazolam	Alprazolam	83	26
Torsemide	Torsemide	79	21
Tamsulosin Hcl	Tamsulosin Hcl	78	27
Oxycodone Hcl	Oxycodone Hcl	75	25
Escitalopram Oxalate	Escitalopram Oxalate	74	24
Zolpidem Tartrate	Zolpidem Tartrate	67	17
Glipizide Er	Glipizide	65	19
Pravastatin Sodium	Pravastatin Sodium	58	18
Potassium Chloride	Potassium Chloride	54	16
Chlorthalidone	Chlorthalidone	53	14
Doxazosin Mesylate	Doxazosin Mesylate	53	16
Ozempic	Semaglutide	51	suppressed
Prednisone	Prednisone	51	32
Famotidine	Famotidine	50	12
Duloxetine Hcl	Duloxetine Hcl	49	suppressed
Carvedilol	Carvedilol	48	16
Finasteride	Finasteride	47	11
Labetalol Hcl	Labetalol Hcl	46	14
Alfuzosin Hcl Er	Alfuzosin Hcl	45	13
Fluticasone Propionate	Fluticasone Propionate	45	18
Tramadol Hcl	Tramadol Hcl	45	15
Diclofenac Sodium	Diclofenac Sodium	43	15
Furosemide	Furosemide	43	16
Pantoprazole Sodium	Pantoprazole Sodium	43	16
Nifedipine Er	Nifedipine	42	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	11
Mirtazapine	Mirtazapine	39	14
Irbesartan	Irbesartan	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	11
Clonazepam	Clonazepam	36	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	32	26
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Spironolactone	Spironolactone	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Lidocaine	Lidocaine	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Azithromycin	Azithromycin	25	23
Ketoconazole	Ketoconazole	25	23
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Cephalexin	Cephalexin	23	17
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	13
Xarelto	Rivaroxaban	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Fentanyl	Fentanyl	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Mounjaro	Tirzepatide	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	13
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Atenolol	Atenolol	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Baclofen	Baclofen	14	suppressed
Colchicine	Colchicine	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Pulmicort Flexhaler	Budesonide	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Glyburide	Glyburide	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	11
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error